Richard Y. Cheng, a distinguished member at Ritter Spencer Cheng PLLC, brings a wealth of experience and expertise in corporate transactions, regulatory, compliance matters, and administrative appeals. His profound knowledge of healthcare and corporate M&A law has led him to represent a diverse range of investment platforms (e.g. private equity, family offices, venture capital funds) and healthcare providers ranging from post-acute care providers (e.g. skilled nursing facilities, assisted living facilities, hospices, and home health agencies), hospitals, physician groups, ancillary providers, behavioral health facilities, management service organizations, dental services organizations, NPHOs and veterinarians. Richard’s adeptness in navigating various healthcare regulations has solidified his reputation as a trusted legal advisor in healthcare law.
At Ritter Spencer Cheng PLLC, Richard leads the healthcare and corporate M&A practice, offering representation to a broad range of investors, healthcare organizations and providers. His extensive background includes dealing with the Stark Law, the Anti-Kickback Statute, the False Claims Act, HIPAA, EKRA, CMP assessments, corporate practice of medicine and dentistry laws, and state related regulations.
In addition to his traditional healthcare practice, Richard developed a cannabis regulatory and corporate practice starting in late 2013. As a leading cannabis attorney, Richard served as outside general counsel to the Texas Cannabis Industry Association, co-authored a FDA primer in preparation for the 2019 FDA public hearing on CBD products and has been named a top 250 cannabis legal expert by DataBird Research Journal. He represents a broad base of cannabis related clients, including, private equity groups investing in the cannabis industry, physicians, medical marijuana dispensaries, seed developers, cultivators, processors, wholesalers, retailers, distribution centers and ancillary providers (e.g. testing labs, biomass brokerage firms, etc.) and marketers.
